“Innovation: Sparking the Flame”
Thursday, July 14, 2011
H&R Block Headquarters
One H&R Block Way
Kansas City , MO 64105
RSVP online >>
Revitalize your team at The Chamber's 2011 Innovation Conference scheduled for July 14 at H&R Block World Headquarters. We can help you inspire great ideas from those around you and learn how to turn those concepts into reality.
Our high-energy, resource-packed, full-day conference begins with a keynote from Dennis Bushnell, Chief Scientist for NASA's Langley Research Center. He'll discuss the concept of IDEATION, the creation & evaluation of ideas.
Breakout sessions will follow two tracks: building a regional culture of innovation and success stories from local innovators at every stage of business. We'll also have a midday keynote covering Kansas City's rich history of innovation and a closing keynote addressing the future of innovation in our region.
During periods of economic turbulence such as this one, it is natural for business leaders to go back to the “well,” so to speak, to drum up new business or put forth new efforts to innovate within your company. Here are some thoughts, strategies, and knowledge that may help in looking to assets and resources in your area or innovative regions that could propel your efforts.
The End Game Innovation has been and should remain the end game, since it is truly how companies are driving and sustaining growth in today’s economy. And innovation is not just defined through the building of new products; it is also the creation and transformation of knowledge and new processes and services that meet a market need. It’s about new ways to partner, and innovative interactions, entertainment forms, and ways of communicating and collaborating. Innovation truly distinguishes the leaders in today’s economy.
Gust, the investor relations platform connecting high-growth entrepreneurs and active early stage investors, and DiligentDeal, a conference organizer in the early stage investment space, will host their first annual conference, Venture Forward 2012, in New York City on Thursday, June 20. The day-long event, taking place at the New York Academy of Sciences, will convene the country’s leading angel investors and early-stage venture capitalists to collaborate and share industry insights on the rapidly evolving early stage investing market through a series of interactive panel discussions, keynote addresses and fireside interviews.
“The landscape of equity funding for early-stage entrepreneurial ventures is undergoing a revolution. Venture Forward 2012 will bring together the industry’s leaders for a high-level knowledge exchange about the challenges and opportunities facing early stage investors, and the rapidly changing legislative and economic landscape,” said David S. Rose, CEO of Gust and one of the country’s most active super-angel investors. “The conference will provide an exclusive opportunity for attendees to learn from, and engage with, the world-class investors and financial technology entrepreneurs who are at the forefront of these changes.”
Chairman Quayle and Ranking Member Edwards, thank you for the opportunity to testify before the House Science, Space and Technology Committee’s Subcommittee on Technology and Innovation on the important topic of “Fostering the U.S. Competitive Edge: Examining the Effect of Federal Policies on Competition, Innovation, and Job Growth.”
My name is Richard Bendis and I am the President and CEO of BioHealth Innovation Inc., (BHI). BHI is a private-public partnership that is predominantly funded by the private sector to foster biohealth innovation-based economic development, which is a unique cluster-based model for regional economic development. This initiative could be used as a model program regardless of industry or cluster strength.
BHI is the first regionally focused innovation intermediary created to connect the university and hospital biohealthresearch strengths of Baltimore with the bioscience industry and federal laboratory strengths of Montgomery County. It has entered into a Partnership Intermediary Agreement with the National Institutes of Health's Office of Technology Transfer and has created the first private-sector funded Entrepreneur in Residence (EIR) program to identify commercializable science in the 27 institutes of NIH. This program will create new project-based companies and high-paying life science jobs. BHI believes this EIR program is applicable to many federal agencies that have technology transfer offices and support SBIR programs.
BHI has designed a potential national pilot, the Health-Regional Innovation Cluster (H-RIC) model, which will incorporate the best innovation-based economic development practices in the United States and integrate them into one region in Central Maryland. BHI is currently seeking federal financial support from several relevant federal agency partners to accelerate the creation and implemention of this innovative biohealth H-RIC model.
BioHealth Innovation, Inc. (BHI), a regional private-public partnership focusing on commercializing market-relevant biohealth innovations and increasing access to early-stage funding in Central Maryland, announced today that its Board of Directors has named former Interim CEO Richard Bendis as the organization's first President & Chief Executive Officer.
Scott Carmer, BioHealth Innovation, Inc. Chairman of the Board and Executive Vice President of Commercial Operations at MedImmune, said, "The Board unanimously supported the appointment of Rich Bendis as BHI's President and CEO. As the interim CEO, Rich has been instrumental in establishing BHI, securing significant private and public sector support and funding, and developing and executing on long- and short-term strategic goals. Rich possesses unique knowledge and experience that will allow him to continue BHI's tremendous momentum to accelerate biohealth commercialization opportunities for Central Maryland."